XML 125 R111.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
SEGMENT INFORMATION Profitability (Details)
$ in Millions
12 Months Ended
Oct. 31, 2019
USD ($)
segment
Oct. 31, 2018
USD ($)
Oct. 31, 2017
USD ($)
Segment Reporting [Abstract]      
Number of operating segments | segment 3    
Percentage of revenue from a single customer Less than 10 percent Less than 10 percent Less than 10 percent
Select income statement components      
Net revenue $ 5,163 $ 4,914 $ 4,472
Income from operations 941 904 807
Depreciation expense 111 102 94
Share-based compensation 72 70 60
Life Sciences and Applied Markets      
Select income statement components      
Net revenue 2,302 2,270 2,081
Income from operations 542 543 470
Depreciation expense 41 38 35
Share-based compensation 33 33 30
Diagnostics and Genomics      
Select income statement components      
Net revenue 1,021 943 860
Income from operations 185 173 167
Depreciation expense 35 33 30
Share-based compensation 14 14 10
Agilent CrossLab      
Select income statement components      
Net revenue 1,840 1,701 1,531
Income from operations 475 388 336
Depreciation expense 35 31 29
Share-based compensation 25 24 21
Segment Total [Member]      
Select income statement components      
Net revenue 5,163 4,914 4,472
Income from operations 1,202 1,104 973
Depreciation expense 111 102 94
Share-based compensation $ 72 $ 71 $ 61